semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-35.0,  Body Weight Contraceptive Usage Age 18-35 BMI > 30kg/m2 Proof of a normal breast and pelvic exam within last 9 months Self reported normal menstrual periods (24-35 days) Good general health In the investigator's opinion, are subject's veins suitable the repeat blood draws dictated by study protocol Single progesterone level during screening visit ≥ 3ng/mL Hematocrit ≥ 36%  Contradictions to COCs (history of deep vein thrombosis,myocardial infection, uncontrolled hypertension, pulmonary embolus, diabetes with vascular changes, stroke, migraines with neurologic changes, breast cancer, impaired liver function, uncontrolled thyroid disease, hypersensitivity or allergy to birth control) Smoker (must smoke 0 cigarettes) Actively seeking/involved in a weight loss program Currently pregnant/seeking pregnancy in the next 6 months Currently breast-feeding Past or current diagnosis of polycystic ovarian disease Recent use of birth control (Depot medroxyprogesterone: 6 months, Progestin implants: 6 months, Oral contraceptives, patch or ring: 2 months, Hormone impregnated IUD: 6 months) Currently taking medication that interferes with COC's (Rifampin, Carbamazepine, St. John's Wort)
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-35.0,  Polycystic Ovarian Syndrome Female subjects with PCO or Polycystic ovary syndrome (PCOS) according to the revised 2003 Rotterdam Consensus Female subjects suitable for IVF/ICSI, undergoing first or second attempt 35 years old, Body Mass Index (BMI) less than or equal to 32, non-smoking at least from Visit 0 (V0) Normal FSH value (less than 10 international unit per liter [IU/L]) on Day 3 of spontaneous cycle within 12 months prior to the trial Anti Mullerian Hormone (AMH) value (greater than 1.5 nanogram per milliliter [ng/mL]) of a spontaneous cycle within 12 months prior to the trial or at least at V0 No history of active genito-urinary infection Normal thyroid function (or adequate substitution for at least 3 months) Negative cervical papanicolaou test within the last 12 months prior to study entry No gonadotropins, for at least one month prior to the trial No metformin therapy for at least one month prior to Visit 1 (V1)  Ongoing pregnancy, any pregnancy within 3 months prior to study entry, or any contraindication to pregnancy or carrying pregnancy to term Drilling 3 months prior to V0 Uterine malformation, diethylstilbestrol syndrome, synechia Female subjects with World Health Organization (WHO) Type I or III anovulation Female subjects with hyperprolactinemia Female subjects with more than 2 recurrent miscarriages (early or late, and for any reasons) Known infection with Human Immunodeficiency Virus (HIV), Hepatitis B or C virus, for subject or partner Abnormal gynecological bleeding of undetermined origin History of major thromboembolic disease Endometriosis (Grade III or IV)
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 0.0-4.0,  Infant, Newborn Infant, Small for Gestational Age Infant, Very Low Birth Weight Infant, Premature Intracranial Hemorrhages Less than 27 completed weeks gestational age Birth weight less than 1,000 grams Inborn infants  Infant's treatment will be limited based on poor prognosis Umbilical cord or blood pH below 7.0 Antenatally diagnosed brain abnormality, including hemorrhage Major congenital malformations, including those for which feeding is contraindicated Mother of infant enrolled in a clinical trial of vitamin E supplementation Mother of infant reports self administration of monovitamin supplements of vitamin E during pregnancy or labor Infant has received supplemental vitamin E (except multivitamin additive in parenteral nutrition or through enteral milk or formula feeds) Greater than four hours of age
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Obesity abdominal obesity  BMI > 45, previous weight change
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Morbid Obesity Age: 18 years BMI 35-39.9 kg/m2 with one or more severe co-morbid conditions or BMI 40-55 kg/m2 Willingness to comply with dietary restrictions required by the protocol History of obesity for at least 5 years History of at least 6 months of documented failures with traditional non-surgical weight loss methods Willingness to follow protocol requirements which signing the informed consent form, completing routine follow-up visits for the study duration, and completing all pre and post-operative laboratory and diagnostics tests in addition to the quality of life questionnaire If female with childbearing potential, using an appropriate form of contraception  Age less than 18, age greater than 60 Pregnancy History of major depressive disorder or psychosis Previous bariatric surgery or previous gastric surgery Presence of achalasia Any condition that, in the judgment of the investigator, would place a subject at undue risk, or could potentially compromise the results or interpretation of the study
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Obstructive Sleep Apnea Syndrome BMI ≥ 30 kg/M2 Apne hypopnea index (AHI) > 10 No significant comorbidities Abel to exercise  Inability to exercise due to musculoskeletal conditions Known ischemic cardiovascular disease Drug abuse Mental illnesses
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 30.0-80.0,  Diabetes Mellitus, Type 2 AND Metformin Mild hyperglycemia, no contraindication for metformin, poor controlled diabetes  Creatinine more than 1.5, severe organ damage
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 21.0-70.0,  Cardiovascular Disease Hyperlipidemia healthy non-smoking overweight (BMI 25-35 kg/m2) men and women LDL-C between the25-90th percentile from 105-194mg/dL for males; 98-190mg/dL for females)  BP >140/90 mmHg A history of myocardial infarction, stroke, diabetes mellitus, liver disease, kidney disease, and thyroid disease (unless controlled on medication) Lactation, pregnancy, or desire to become pregnant during the study Cholesterol-lowering medication use Intake of putative cholesterol-lowering supplements (psyllium, fish oil capsules, soy lecithin, niacin, fiber, flax, and phytoestrogens, stanol/sterol supplemented foods) Vegetarianism Nut allergies (Other food allergies were reviewed on a case-by-case basis) Refusal to discontinue nutritional supplements, herbs or vitamins
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Obesity Morbid obesity 50 years of age Having a relative or close friend who is willing to participate  Pregnancy Serious mental illness Severe overeating behaviour Significant reduced physical functioning Having undergone bariatric surgery earlier Serious heart disease
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 20.0-55.0,  Abdominal Fat Body Weight Healthy subject, as determined by clinical examination, and medical history Non-menopausal woman BMI between 27 and 34 kg/m² Waist circumference > 80 cm No diet within the last 3 months with weight loss or gain not more than 3kg Non-smoking subject, or smoking less than 15 cigarettes/day since three months Normal blood pressure (BP) and heart rate (HR) after 10 minutes in supine position. Individuals values out of the normal range can be accepted if judged clinically non relevant by the investigator Laboratory parameters within the normal range of the laboratory (haematological, blood chemistry tests, urinalysis). Individual values out of the normal range can be accepted if judged clinically non relevant by the Investigator Subject with a habitual low (< 16 g/day) intake of whole grain foods (from cereal food intake questionnaire) willing to eat breakfast cereals  Subject having a history of metabolic disease (i.e, diabetes) Subject suffering from chronic renal insufficiency Subject receiving a local or general treatment (i.e, prescription medications, over-the-counter medications, dietary supplements or herbal supplements) susceptible to interfere with the evaluation of the studied parameters and in particular weight (eg, appetite suppressants, slimming or treatment which could interfere with the metabolism and dietary behaviour) Subject with ongoing medication not stabilized since more than 3 months Subject having had a general anaesthesia in the month preceding or gastro-intestinal surgery at any time in his/her life, with the possible exception of appendectomy Pregnant or breast-feeding subject (positive urinary pregnancy test) Subject in an period of a previous study or having participated in another clinical study in the last month Use of laxatives, except in few occasions, if, in the opinion of the investigator, does not interfere with the optimal participation Subject having received more than 4500 Euros in indemnity for participation in clinical studies in the last 12 months, including participation in the present study Subject in a situation that, in the opinion of the investigator, could interfere with his optimal participation in the study or constitute a particular risk for the subject
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 21.0-50.0,  Obesity Pre-menopausal BMI (25 Weight < 300 lbs Negative urine glucose test  Inability to provide informed consent Age < 21 or menopausal as determined by self-report DSM-IV diagnosis of an eating disorder Any substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate in the intervention Factors that confound relations between stress and eating, including, drug abuse and use of medications containing corticosteroids Diabetes Polycystic Ovary Syndrome CHD Breastfeeding (due to interference with stress hormone measurement) Non English speaker
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Ischemic Stroke Transient Ischemic Attack Atherosclerotic Stenosis • Recent (less than 3 months) ischemic stroke As soon as possible after the event, once the neurologic deficit is stabilized (investigator judgment) These ischemic strokes TIA with ischemic lesion documented by CT or MRI • Or recent TIA (less than 15 days) without documentation of ischemic lesion on CT/MR imaging Must be limb weakness or aphasia lasting more than 10 min • And documented atherosclerotic stenosis In carotid artery (investigator judgment) (based on the results of Duplex echography, CTA, MRA or X ray angiography) Or in the aortic arch (investigator judgment) (based on TEE or CTA) Or in other brain artery: vertebral, basilar or other intracranial artery (based on CTA, MRA, XRA) Or in coronary arteries (past history of acute coronary syndrome, coronary revascularization or positive coronary angiography) • And  • Ischemic stroke/TIA du to arterial dissection (investigator judgment) Cardiac source of embolism (e.g., mitral stenosis, endomyocardial fibrosis) without documented atherosclerotic stenosis : a patient with atrial fibrillation or a past history of recent myocardial infarction or calcified aortic stenosis can be randomized if he otherwise fulfils • Symptomatic hemorrhagic stroke Presence of microbleeds on gradient echo imaging (T2*) is not an Hemorrhagic transformation of an ischemic stroke is not an Uncontrolled hypertension (investigator judgment) LDL-C <100 mg/dL or patients for whom treatment intensification is impossible F/U impossible or bad observance anticipated Co-morbid condition that may interfere with the F/U or with the evaluation of primary endpoint Participation to another clinical trial
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 20.0-50.0,  Obesity BMI above 24 kg/m2, or the either one ( fat mass ≧ 30% or waistline > 80 cm )  Cardiovascular disease type 2 diabetes mellitus or impaired glucose tolerance serious liver or renal disease, gastro-intestinal disease proceed serious diet control for formerly three months take any supplemental food products or medications known to influence lipid or carbohydrate metabolism
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 15.0-45.0,  Polycystic Ovary Syndrome Metabolic Syndrome Cardiovascular Disease women at reproductive age women with PCOS and women without PCOS  young women who had their menarche less than 3 years women older than 45 years old, Amenorrhea of menopause, hyperglycemia, hyperthyroidism, hypothyroidism, heart failure, lung failure, renal failure, anemia, dystrophy, gonitis